Literature DB >> 19465023

Large scale expansion of Vgamma9Vdelta2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS "TCR gamma/delta+ T cell isolation kit".

Samuel Salot1, Sylvain Bercegeay, Brigitte Dreno, Soraya Saïagh, Virginie Scaglione, Cécile Bonnafous, Hélène Sicard.   

Abstract

Interest in gamma9delta2 T cells has increased greatly in the past decade. While several protocols allowed the amplification of a large proportion of these cells in vitro, the purity of the final preparation is usually heterogeneous between different donors. Functional studies of this population are often controversial due to the presence of other populations such as NK cells which share a wide range of characteristics. Here, the gamma9delta2 T cells labelled-fraction is purified and mixed with the irradiated unlabelled fraction followed by a single stimulation with phosphoantigen, in turn followed by a classical step of amplification in the presence of interleukin 2. In this study, we describe a straightforward protocol to amplify pure populations of gamma9delta2 T cells which could be useful in fundamental research or in the development of a new generation of gammadelta cell therapy protocol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465023     DOI: 10.1016/j.jim.2009.05.006

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

Review 1.  γδ-T cells: an unpolished sword in human anti-infection immunity.

Authors:  Jian Zheng; Yinping Liu; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2012-10-15       Impact factor: 11.530

2.  Efficient recovery of potent tumour-infiltrating lymphocytes through quantitative immunomagnetic cell sorting.

Authors:  Zongjie Wang; Sharif Ahmed; Mahmoud Labib; Hansen Wang; Xiyue Hu; Jiarun Wei; Yuxi Yao; Jason Moffat; Edward H Sargent; Shana O Kelley
Journal:  Nat Biomed Eng       Date:  2022-01-27       Impact factor: 29.234

Review 3.  What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

Authors:  Jean-Jacques Fournié; Hélène Sicard; Mary Poupot; Christine Bezombes; Amandine Blanc; François Romagné; Loic Ysebaert; Guy Laurent
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

4.  Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model.

Authors:  Gabrielle M Siegers; Tania C Felizardo; A Mark Mathieson; Yoko Kosaka; Xing-Hua Wang; Jeffrey A Medin; Armand Keating
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

5.  Human γδ T lymphocytes for immunotherapeutic strategies against cancer.

Authors:  Dieter Kabelitz
Journal:  F1000 Med Rep       Date:  2010-06-23

Review 6.  Targeted Therapies in Adult B-Cell Malignancies.

Authors:  Jean-François Rossi
Journal:  Biomed Res Int       Date:  2015-09-06       Impact factor: 3.411

7.  Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells.

Authors:  Forrest L Baker; Austin B Bigley; Nadia H Agha; Charles R Pedlar; Daniel P O'Connor; Richard A Bond; Catherine M Bollard; Emmanuel Katsanis; Richard J Simpson
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

8.  Enrichment of human Vγ9Vδ2 T lymphocytes by magnetic poly(divinylbenzene-co-glycidyl methacrylate) colloidal particles conjugated with specific antibody.

Authors:  Piamsiri Sawaisorn; Tienrat Tangchaikeeree; Duangporn Polpanich; Panuwat Midoeng; Rachanee Udomsangpetch; Abdelhamid Elaissari; Kulachart Jangpatarapongsa
Journal:  RSC Adv       Date:  2018-04-17       Impact factor: 4.036

9.  Human adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.

Authors:  Jan Dörrie; Christian Krug; Christian Hofmann; Ina Müller; Verena Wellner; Ilka Knippertz; Stephan Schierer; Simone Thomas; Elke Zipperer; Dieter Printz; Gerhard Fritsch; Gerold Schuler; Niels Schaft; Rene Geyeregger
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

10.  Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells.

Authors:  Heleen H Van Acker; Sébastien Anguille; Yannick Willemen; Johan M Van den Bergh; Zwi N Berneman; Eva Lion; Evelien L Smits; Viggo F Van Tendeloo
Journal:  J Hematol Oncol       Date:  2016-09-29       Impact factor: 17.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.